Loading...
A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report
Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...
Saved in:
| Published in: | J Cardiol Cases |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Japanese College of Cardiology
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/ https://ncbi.nlm.nih.gov/pubmed/30279790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|